DNA damage-induced activation of p53 by the checkpoint kinase Chk2

被引:1004
|
作者
Hirao, A
Kong, YY
Matsuoka, S
Wakeham, A
Ruland, J
Yoshida, H
Liu, D
Elledge, SJ
Mak, TW
机构
[1] Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[4] Baylor Coll Med, Howard Hughes Med Inst, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
关键词
D O I
10.1126/science.287.5459.1824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chk2 is a protein kinase that is activated in response to DNA damage and may regulate cell cycle arrest. We generated Chk2-deficient mouse cells by gene targeting. Chk2(-/-) embryonic stem cells failed to maintain gamma-irradiation-induced arrest in the Ci phase of the cell cycle. Chk2(-/-) thymocytes were resistant to DNA damage-induced apoptosis. Chk2(-/-) cells were defective for p53 stabilization and for induction of p53-dependent transcripts such as p21 in response to gamma irradiation. Reintroduction of the Chk2 gene restored p53-dependent transcription in response to gamma irradiation. Chk2 directly phosphorylated p53 on serine 20, which is known to interfere with Mdm2 binding. This provides a mechanism for increased stability of p53 by prevention of ubiquitination in response to DNA damage.
引用
收藏
页码:1824 / 1827
页数:4
相关论文
共 50 条
  • [41] Activation of checkpoint kinase Chk2 by cisplatin and its role in cisplatin resistance
    Liang, Xiaobing
    Mueller, Michael D.
    Yu, Jing Jie
    CANCER RESEARCH, 2010, 70
  • [42] DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats
    Yan, H-X
    Wu, H-P
    Zhang, H-L
    Ashton, C.
    Tong, C.
    Wu, J.
    Qian, Q-J
    Wang, H-Y
    Ying, Q-L
    ONCOGENE, 2013, 32 (38) : 4565 - 4571
  • [43] DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1 -: The lack of this suppression in p53MUT cells contributes to apoptosis
    Bhonde, MR
    Hanski, ML
    Budczies, J
    Cao, M
    Gillissen, B
    Moorthy, D
    Simonetta, F
    Scherübl, H
    Truss, M
    Hagemeier, C
    Mewes, HW
    Daniel, PT
    Zeitz, M
    Hanski, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (13) : 8675 - 8685
  • [44] A mitotic role for the DNA damage-responsive CHK2 kinase
    Sato, Ko
    Ohta, Tomohiko
    Venkitaraman, Ashok R.
    NATURE CELL BIOLOGY, 2010, 12 (05) : 424 - 425
  • [45] UCN-01 inhibits p53 up-regulation and abrogates γ-radiation-induced G2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1
    Yu, Q
    La Rose, J
    Zhang, HL
    Takemura, H
    Kohn, KW
    Pommier, Y
    CANCER RESEARCH, 2002, 62 (20) : 5743 - 5748
  • [46] A mitotic role for the DNA damage-responsive CHK2 kinase
    Ko Sato
    Tomohiko Ohta
    Ashok R. Venkitaraman
    Nature Cell Biology, 2010, 12 : 424 - 425
  • [47] DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53
    Woo, RA
    Jack, MT
    Xu, Y
    Burma, S
    Chen, DJ
    Lee, PWK
    EMBO JOURNAL, 2002, 21 (12): : 3000 - 3008
  • [48] Mafosfamide induced apoptosis in human lymphoblastoid cells: Role of DNA replication, RNA transcription, p53 and Chk1/Chk2
    Goldstein, M.
    Roos, W. P.
    Kaina, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 82 - 82
  • [49] DNA Damage-Induced RORα Is Crucial for p53 Stabilization and Increased Apoptosis
    Kim, Hyunkyung
    Lee, Ji Min
    Lee, Gina
    Bhin, Jinhyuk
    Oh, Se Kyu
    Kim, Kyeongkyu
    Pyo, Ki Eun
    Lee, Jason S.
    Yim, Hwa Young
    Kim, Keun Il
    Hwang, Daehee
    Chung, Jongkyeong
    Baek, Sung Hee
    MOLECULAR CELL, 2011, 44 (05) : 797 - 810
  • [50] COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis
    Choi, EM
    Heo, JI
    Oh, JY
    Kim, YM
    Ha, KS
    Kim, JI
    Han, JA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (04) : 1107 - 1112